These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 6617723)
1. Continuous infusion of high-dose metoclopramide for the prevention of nausea and vomiting in patients receiving cancer chemotherapy. Joss RA; Galeazzi RL; Brunner KW Eur J Clin Pharmacol; 1983; 25(1):35-9. PubMed ID: 6617723 [TBL] [Abstract][Full Text] [Related]
2. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation. Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333 [TBL] [Abstract][Full Text] [Related]
3. Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy. Strum SB; McDermed JE; Opfell RW; Riech LP JAMA; 1982 May; 247(19):2683-6. PubMed ID: 7043002 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting. Taylor WB; Proctor SJ; Bateman DN Br J Clin Pharmacol; 1984 Nov; 18(5):679-84. PubMed ID: 6508977 [TBL] [Abstract][Full Text] [Related]
5. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin. Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968 [TBL] [Abstract][Full Text] [Related]
6. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience. Sorbe BG Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123 [TBL] [Abstract][Full Text] [Related]
7. Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy. Navari RM; Province WS; Perrine GM; Kilgore JR Cancer; 1993 Jul; 72(2):583-6. PubMed ID: 8319191 [TBL] [Abstract][Full Text] [Related]
8. Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy. Osoba D; Erlichman C; Willan AR; Levitt M; Pater JL Clin Invest Med; 1986 Nov; 9(4):225-31. PubMed ID: 3542325 [TBL] [Abstract][Full Text] [Related]
9. Comparison of continuous and intermittent bolus infusions of metoclopramide during 5-day continuous intravenous infusion with cisplatin. Mori K; Saitou Y; Tominaga K; Yokoi ; Miyazawa N Eur J Cancer; 1991; 27(6):729-32. PubMed ID: 1648944 [TBL] [Abstract][Full Text] [Related]
10. Antiemetic activity of high-dose methylprednisolone associated with continuous-infusion metoclopramide and oral alprazolam during multiple-day chemotherapy. Salles G; Archimbaud E; Thomas X; Fiere D Cancer Chemother Pharmacol; 1991; 28(1):77-9. PubMed ID: 2040038 [TBL] [Abstract][Full Text] [Related]
11. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial. Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041 [TBL] [Abstract][Full Text] [Related]
12. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study. De Mulder PH; Seynaeve C; Vermorken JB; van Liessum PA; Mols-Jevdevic S; Allman EL; Beranek P; Verweij J Ann Intern Med; 1990 Dec; 113(11):834-40. PubMed ID: 2146911 [TBL] [Abstract][Full Text] [Related]
13. A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil. Shiu W; Tsang V; Lam YM; Zacharia A; Martin WM Cancer Chemother Pharmacol; 1987; 20(3):259-62. PubMed ID: 3315286 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. Gilbert CJ; Ohly KV; Rosner G; Peters WP Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039 [TBL] [Abstract][Full Text] [Related]
15. [Metoclopramide, methylprednisolone and flunitrazepam in cytostatic-induced vomiting]. Joss R; Rohrbach D; Pirovino M; Bischoff A; Kiser J; Brunner K Schweiz Med Wochenschr; 1987 Dec; 117(52):2113-7. PubMed ID: 3433092 [TBL] [Abstract][Full Text] [Related]
16. Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy. Allen JC; Gralla R; Reilly L; Kellick M; Young C J Clin Oncol; 1985 Aug; 3(8):1136-41. PubMed ID: 4020411 [TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854 [TBL] [Abstract][Full Text] [Related]
18. [High dose metoclopramide during cancer chemotherapy. Phase II study in 80 consecutive patients]. Bui NB; Marit G; Albin H; Durand M; Mauriac L; Hoerni B Bull Cancer; 1982; 69(4):330-5. PubMed ID: 7150789 [TBL] [Abstract][Full Text] [Related]
19. High-dose metoclopramide by infusion: a double-blind study of plasma concentration-effect relationships in patients receiving cancer chemotherapy. Taylor WB; Simpson JM; Bateman DN Eur J Clin Pharmacol; 1987; 33(2):161-5. PubMed ID: 3319642 [TBL] [Abstract][Full Text] [Related]